Effect of long-term blood pressure trajectory on the future development of chronic kidney disease: an analysis of data from the Korean National Insurance Health Checkup Study
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
OBJECTIVES Chronic kidney disease (CKD) is a prevalent health issue that causes the irreversible loss of functioning nephrons, end-stage renal disease, cardiovascular disease, and premature mortality. Hypertension is the leading cause of CKD. However, the effect of long-term blood pressure (BP) changes on the development of CKD is still unknown. Therefore, the current study investigated the association between BP trajectory and the future development of CKD. METHODS In this study, 246,874 individuals aged ≥40 years who underwent health examinations during the screening period (2002-2009) were evaluated. The systolic blood pressure (SBP) trajectory was determined using latent-class mixture modeling. New-onset CKD was identified during the follow-up period (2010-2019). The association between SBP trajectories and new-onset CKD was assessed. RESULTS In total, 111,900 adults (53,420 females, 51.9±6.4 years old) presented with 2 SBP trajectory classes: class 1 (n=66,935) and class 2 (n=44,965). During the follow-up period, patients with SBP trajectory class 2 had an approximately 2.1-fold increased risk of developing CKD (unadjusted hazard ratio [HR], 2.11; 95% confidence interval [CI], 1.99 to 2.25; p<0.001). In the multivariate analysis adjusted for other significant variables, SBP trajectory class 2 was significantly associated with CKD in males (HR, 1.09; 95% CI, 1.00 to 1.19; p=0.037), but not in females (HR, 1.06; 95% CI, 0.95 to 1.18; p=0.321). CONCLUSIONS An elevated longitudinal BP was associated with a higher incidence of CKD in male participants aged ≥40 years. Nevertheless, further studies are needed to validate the clinical significance of an elevated SBP trajectory on CKD development.
Abstract
OBJECTIVES Chronic kidney disease (CKD) is a prevalent health issue that causes the irreversible loss of functioning nephrons, end-stage renal disease, cardiovascular disease, and premature mortality. Hypertension is the leading cause of CKD. However, the effect of long-term blood pressure (BP) changes on the development of CKD is still unknown. Therefore, the current study investigated the association between BP trajectory and the future development of CKD. METHODS In this study, 246,874 individuals aged ≥40 years who underwent health examinations during the screening period (2002-2009) were evaluated. The systolic blood pressure (SBP) trajectory was determined using latent-class mixture modeling. New-onset CKD was identified during the follow-up period (2010-2019). The association between SBP trajectories and new-onset CKD was assessed. RESULTS In total, 111,900 adults (53,420 females, 51.9±6.4 years old) presented with 2 SBP trajectory classes: class 1 (n=66,935) and class 2 (n=44,965). During the follow-up period, patients with SBP trajectory class 2 had an approximately 2.1-fold increased risk of developing CKD (unadjusted hazard ratio [HR], 2.11; 95% confidence interval [CI], 1.99 to 2.25; p<0.001). In the multivariate analysis adjusted for other significant variables, SBP trajectory class 2 was significantly associated with CKD in males (HR, 1.09; 95% CI, 1.00 to 1.19; p=0.037), but not in females (HR, 1.06; 95% CI, 0.95 to 1.18; p=0.321). CONCLUSIONS An elevated longitudinal BP was associated with a higher incidence of CKD in male participants aged ≥40 years. Nevertheless, further studies are needed to validate the clinical significance of an elevated SBP trajectory on CKD development.
참고문헌 (30)
- Ruiz-Ortega M, "Targeting the progression of chronic kidney disease", Nat Rev Nephrol, 16, pp.269~288 (2020)[DOI]
- Meguid El Nahas A, "Chronic kidney disease : the global challenge", Lancet, 365, pp.331~340 (2005)[DOI]
- Bidani AK, "Pathophysiology of hypertensive renal damage : implications for therapy", Hypertension, 44, pp.595~601 (2004)[DOI]
- Mennuni S, "Hypertension and kidneys : unraveling complex molecular mechanisms underlying hypertensive renal damage", J Hum Hypertens, 28, pp.74~79 (2014)[DOI]
- Hsu CY, "Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease", Arch Intern Med, 165, pp.923~928 (2005)[DOI]
- Sim JJ, "Impact of achieved blood pressures on mortality risk and end-stage renal disease among a large, diverse hypertension population", J Am Coll Cardiol, 64, pp.588~597 (2014)[DOI]
- Allen NB, "Blood pressure trajectories in early adulthood and subclinical atherosclerosis in middle age", JAMA, 311, pp.490~497 (2014)[DOI]
- Tielemans SM, "Ten-year blood pressure trajectories, cardiovascular mortality, and life years lost in 2 extinction cohorts : the Minnesota Business and Professional Men Study and the Zutphen Study", J Am Heart Assoc, 4, pp.e001378~ (2015)[DOI]
- Allen NB, "Blood pressure trajectories across the life course", Am J Hypertens, 34, pp.234~241 (2021)[DOI]
- Joo YS, "Association between longitudinal blood pressure trajectory and the progression of chronic kidney disease : results from the KNOW-CKD", Hypertension, 78, pp.1355~1364 (2021)[DOI]
- Lee J, "Cohort profile : the National Health Insurance Service-National Sample Cohort(NHIS-NSC), South Korea", Int J Epidemiol, 46, pp.e15~ (2017)[DOI]
- Reges O, "Body mass index trajectories among people with obesity and association with mortality : evidence from a large Israeli database", Obes Sci Pract, 7, pp.148~158 (2020)[DOI]
- Guo T, "The association of long-term trajectories of BMI, its variability, and metabolic syndrome : a 30-year prospective cohort study", EClinicalMedicine, 69, pp.102486~ (2024)[DOI]
- Nagin DS, "Group-based trajectory modeling(nearly)two decades later", J Quant Criminol, 26, pp.445~453 (2010)[DOI]
- Nagin DS, "Group-based trajectory modeling in clinical research", Annu Rev Clin Psychol, 6, pp.109~138 (2010)[DOI]
- Burnier M, "Hypertension as cardiovascular risk factor in chronic kidney disease", Circ Res, 132, pp.1050~1063 (2023)[DOI]
- Flint AC, "Effect of systolic and diastolic blood pressure on cardiovascular outcomes", N Engl J Med, 381, pp.243~251 (2019)[DOI]
- Anderson AH, "Time-updated systolic blood pressure and the progression of chronic kidney disease : a cohort study", Ann Intern Med, 162, pp.258~265 (2015)[DOI]
- Briet M, "Arterial stiffness and pulse pressure in CKD and ESRD", Kidney Int, 82, pp.388~400 (2012)[DOI]
- O’Rourke M, "Arterial stiffness, systolic blood pressure, and logical treatment of arterial hypertension", Hypertension, 15, pp.339~347 (1990)[DOI]
- Liu H, "Associations between long-term blood pressure trajectory and all-cause and CVD mortality among old people in China", Front Cardiovasc Med, 10, pp.1157327~ (2023)[DOI]
- Bao M, "Comparison of BP variability, cumulative BP, and BP trajectory for predicting cardiovascular events in the general population", Hellenic J Cardiol, 76, pp.11~21 (2024)[DOI]
- Hao G, "Blood pressure trajectories from childhood to young adulthood associated with cardiovascular risk : results from the 23-year longitudinal Georgia Stress and Heart Study", Hypertension, 69, pp.435~442 (2017)[DOI]
- Kim SH, "Blood pressure trajectories for 16 years and the development of left ventricular hypertrophy and increased left atrial size : the Korean Genome and Epidemiology Study", Int J Hypertens, 2022, pp.6750317~ (2022)[DOI]
- Joo YS, "Association of longitudinal trajectories of systolic BP with risk of incident CKD : results from the Korean Genome and Epidemiology Study", J Am Soc Nephrol, 31, pp.2133~2144 (2020)[DOI]
- Oh KH, "The KNOW-CKD Study : what we have learned about chronic kidney diseases", Kidney Res Clin Pract, 39, pp.121~135 (2020)[DOI]
- Sugahara M, "Update on diagnosis, pathophysiology, and management of diabetic kidney disease", Nephrology(Carlton), 26, pp.491~500 (2021)[DOI]
- Pugliese G, "Diabetic kidney disease : new clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on"The natural history of diabetic kidney disease and treatment of hyperglycemia in patients with type 2 diabetes and impaired renal function"", J Nephrol, 33, pp.9~35 (2020)[DOI]
- Sugandh F, "Advances in the management of diabetes mellitus : a focus on personalized medicine", Cureus, 15, pp.e43697~ (2023)[DOI]
- Weldegiorgis M, "The impact of hypertension on chronic kidney disease and end-stage renal disease is greater in men than women : a systematic review and meta-analysis", BMC Nephrol, 21, pp.506~ (2020)[DOI]